Discover 1,359 paid clinical trials in Athens, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,359
Cognitive Training for Emotion Regulation in Psychotic Disorders
for
Schizophrenia, Schizo Affective Disorder
Location: Athens GA
Sponsor: University of Georgia
Sex: All
Age: 18 - 60
Code: NCT04414215
Recruiting
Steps Towards Osteoarthritis Prevention
for
Anterior Cruciate Ligament Injuries
Location: Athens GA
Sponsor: University of Georgia
Sex: All
Age: 16 - 40
Code: NCT06193343
Recruiting
Postprandial Urolithin Patterns Following Pecan Consumption
for
Change in Plasma Urolithins and Vitamin E
Location: Athens GA
Sponsor: University of Georgia
Sex: All
Age: 18 - 30
Code: NCT06140602
Recruiting
Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
for
Multiple Sclerosis (Relapsing Remitting)
Location: Atlanta GA
Sponsor: Georgia State University
Sex: All
Age: 45 - 70+
Code: NCT06919900
Recruiting
Changes in 24-hour Activity Cycle Behaviors During a Time-Restricted Eating Intervention in College-Aged Women
for
Sleep Quality, Compliance, Physical Activity,
Location: Athens GA
Sponsor: University of Georgia
Sex: Female
Age: 18 - 26
Code: NCT07520786
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Neuroimaging Approaches to Improve Prediction of Smoking Initiation and Nicotine Escalation in Young Adult ENDS Users
for
Message Exposure (Sequence: Regular Then Flavor),
Location: Athens GA
Sponsor: University of Georgia
Sex: All
Age: 18 - 29
Code: NCT05447325
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
for
Clostridioides Difficile Infection
Location: Athens GA, Atlanta GA, Johnson City TN, Salisbury NC,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07285213
Phase2, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Location: Athens GA, Atlanta GA, Birmingham AL, Nashville TN,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06881784
Phase3, Recruiting
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Athens GA, Pinehurst NC, Baltimore MD, Glendale CA
Sponsor: Teligene US
Sex: All
Age: 18+
Code: NCT05168566
Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
for
Non-small Cell Lung Cancer
Location: Athens GA, Tampa FL, New York NY, Houston TX,
Sponsor: Teligene US
Sex: All
Age: 18+
Code: NCT06010329
Phase2, Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: Athens GA, Atlanta GA, Chattanooga TN, Nashville TN,